التفاصيل البيبلوغرافية
| العنوان: |
Adenosine increases PD‐L1 expression in mesenchymal stromal cells derived from cervical cancer through its interaction with A2AR/A2BR and the production of TGF‐β1. |
| المؤلفون: |
Marín‐Aquino, Luis Antonio, Mora‐García, María de Lourdes, Moreno‐Lafont, Martha C., García‐Rocha, Rosario, Montesinos‐Montesinos, Juan José, López‐Santiago, Ruben, Sánchez‐Torres, Luvia Enid, Torres‐Pineda, Daniela Berenice, Weiss‐Steider, Benny, Hernández‐Montes, Jorge, Don‐López, Christian Azucena, Monroy‐García, Alberto |
| المصدر: |
Cell Biochemistry & Function; Apr2024, Vol. 42 Issue 3, p1-12, 12p |
| مصطلحات موضوعية: |
ADENOSINES, STROMAL cells, PROGRAMMED death-ligand 1, TRANSFORMING growth factors-beta, TRANSFORMING growth factors, CERVICAL cancer, T cells |
| مستخلص: |
Mesenchymal stromal cells (MSCs) together with malignant cells present in the tumor microenvironment (TME), participate in the suppression of the antitumor immune response through the production of immunosuppressive factors, such as transforming growth factor beta 1 (TGF‐β1). In previous studies, we reported that adenosine (Ado), generated by the adenosinergic activity of cervical cancer (CeCa) cells, induces the production of TGF‐β1 by interacting with A2AR/A2BR. In the present study, we provide evidence that Ado induces the production of TGF‐β1 in MSCs derived from CeCa tumors (CeCa‐MSCs) by interacting with both receptors and that TGF‐β1 acts in an autocrine manner to induce the expression of programmed death ligand 1 (PD‐L1) in CeCa‐MSCs, resulting in an increase in their immunosuppressive capacity on activated CD8+ T lymphocytes. The addition of the antagonists ZM241385 and MRS1754, specific for A2AR and A2BR, respectively, or SB‐505124, a selective TGF‐β1 receptor inhibitor, in CeCa‐MSC cultures significantly inhibited the expression of PD‐L1. Compared with CeCa‐MSCs, MSCs derived from normal cervical tissue (NCx‐MSCs), used as a control and induced with Ado to express PD‐L1, showed a lower response to TGF‐β1 to increase PD‐L1 expression. Those results strongly suggest the presence of a feedback mechanism among the adenosinergic pathway, the production of TGF‐β1, and the induction of PD‐L1 in CeCa‐MSCs to suppress the antitumor response of CD8+ T lymphocytes. The findings of this study suggest that this pathway may have clinical importance as a therapeutic target. Significance statement: This study provides the first evidence that Ado, when interacting with A2AR or A2BR in CeCa‐MSCs, induces the production of TGF‐β1 and PD‐L1 expression through autocrine action, resulting in an increase in the immunosuppressive capacity of CeCa‐MSCs on activated CD8+ T lymphocytes. [ABSTRACT FROM AUTHOR] |
|
Copyright of Cell Biochemistry & Function is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
